68Ga-FAPI PET/CT for non-invasive characterization and activity assessment of ulcerative colitis and Crohn´s disease
<sup>68</sup>Ga-FAPI-46-PET/CT appears promising for assessing disease activity in terms of fibroblast activation in both CD and UC.
Authors
- Philipp Mildenberger (ORCID: https://orcid.org/0000-0002-7367-1708)
- Marina Lang
- Annika Gauss (ORCID: https://orcid.org/0000-0001-8661-449X)
- Johannes Brandt
- Anna-Maria Spektor (ORCID: https://orcid.org/0009-0005-1092-5773)
- Uwe Haberkorn
- Robert Ehehalt (ORCID: https://orcid.org/0000-0003-4252-5801)
- Frederik M. Glatting
- Manuel Röhrich (ORCID: https://orcid.org/0000-0001-7609-243X)
- Mathias Schreckenberger
- Jürgen Debus
- Isabelle von Götze
- Rahul Kalla
Institutions
- University of Applied Sciences Mainz (DE)
- German Cancer Research Center (DE)
- Johannes Gutenberg University Mainz (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Deutsche Klinik für Diagnostik (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Centre for Inflammation Research (GB)
- University Medical Centre Mannheim (DE)
- Endokrinologikum (DE)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1007/s00259-025-07686-1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00